Injective is falling today: what traders are watching

Traders Union
All News
Crypto News
Injective slips 10.00% today

Highlights

INJ trades at $3.64, firmly below MA-20 ($4.78), MA-50 ($4.83), and MA-200 ($9.35), indicating strong bearish momentum across short, medium, and long-term timeframes.
Momentum indicators including MACD, ADX, RSI (32.71), and Stoch RSI confirm a persistent bearish trend, with INJ entering oversold territory and sellers dominating intraday action.
Technical analysis projects INJ to trade between $3.36 and $3.99 in the coming week, with more than an 80% chance of further price declines.

Anton Kharitonov, expert at Traders Union, highlights that INJ remains stuck below all the critical moving averages. He notes strong bearish momentum in both the short and long term, with heavy selling dominating technical indicators. Kharitonov points to continued pressure as the price is pinned near recent lows and volatility stays elevated. He observes an absence of supportive news, which further erodes trader confidence. "Current signals show no compelling reversal case — caution is essential until INJ reclaims at least one major moving average."

Viktoras Karapetjanc, expert at Traders Union, views the present pullback as part of a volatile yet opportunity-rich market environment. He notes the oversold readings could spark renewed buying interest if resistance levels are challenged. Karapetjanc remains focused on the potential for a sharp rebound should $4.91 be reclaimed. The analyst sees a window for accumulation on weakness, although broader sentiment is subdued. "I believe the setup remains favorable for agile traders — the next trend will favor those alert to quick reversals and emerging momentum."

Technical resistance and oversold signals reinforce intraday selloff

The nearest dynamic resistance is provided by the Ichimoku Kijun at $4.91, while the ongoing configuration signals persistent selling pressure across all timeframes. Momentum indicators such as the MACD and ADX highlight a clear bearish trend, and both RSI (32.71) and CCI (-134.45) show that INJ is entering oversold territory. The Stoch RSI is fully oversold as well, reinforcing negative sentiment, and BBP confirms that sellers dominate intraday action. Persistent downward pressure has kept the price near session lows, with increased volatility and technical momentum confirming the intraday decline.

Previously it was reported that Injective is experiencing strong bearish momentum, with the price trading well below all key moving averages and major indicators such as MACD and RSI confirming clear seller dominance and oversold conditions. With resistance near $4.95 and no significant support in the immediate area, the asset remains vulnerable to further declines or sideways consolidation unless a decisive technical reversal materializes.

Source of Data: INJ Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.